Quest Diagnostics Inc. closed 8.75% short of its 52-week high of $182.38, which the company achieved on June 16th.

Quest Diagnostics (DGX) is a strong buy with growth potential, solid margins, and dividend increases. Discover the full ...

The company plans to make the diagnostic available to physicians and researchers this summer, expanding its portfolio beyond ...

While clinical laboratory Quest Diagnostics (DGX) had a rough outing last week, speculators seeking a discount may want to ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the testing & diagnostics ...

New York Giants rookies officially report for training camp on Tuesday, one week ahead of the remainder of the team.

Before the New York Giants reach training camp, Jaxson Dart was on vacation and showing off his arm strength in a new viral ...

Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts. On June ...

Longtime Seattle Seahawks quarterback Russell Wilson has dealt with more than his fair share of criticism throughout his career, but even that pales in comparis ...

Quest Diagnostics Inc. closed 5.99% below its 52-week high of $182.38, which the company achieved on June 16th.

See the latest Quest Diagnostics Inc stock price (DGX:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...